Flavanones from Sedum sarmentosum Bunge Alleviate CCl₄-Induced Liver Fibrosis in Rats by Targeting TGF-β1/TβR/Smad Pathway In Turn Inhibiting Epithelial Mesenchymal Transition

Table 2

Effect of FSSB on serum activities of AST, ALT, HA, and LN in CCl₄-induced liver fibrosis rats.

Groups	AST (IU·L^−1)	ALT (IU·L^−1)	HA (ng·ml^−1)	LN (ng·ml^−1)
Control	229.08 ± 50.07	58.04 ± 16.44	68.69 ± 15.97	50.94 ± 16.50
Model	485.63 ± 182.1	361.05 ± 246.4	277.21 ± 110.6	72.13 ± 8.6
FSSB	310.49 ± 100.1	205.28 ± 46.89	182.06 ± 38.4	57.98 ± 13.0
FSSB 200	267.90 ± 68.3	181.65 ± 58.2	161.79 ± 51.5	53.40 ± 9.0
FSSB 400	227.05 ± 78.7	171.34 ± 88.4	142.59 ± 67.5	49.30 ± 7.4
Silymarin	254.40 ± 50.3	180.35 ± 54.3	145.83 ± 75.2	51.82 ± 9.2

Control: the normal control group; model: the model group; FSSB 100: the FSSB 100 mg/kg group; FSSB 200: the FSSB 200 mg/kg group; FSSB 400: the FSSB 400 mg/kg group; silymarin: the silymarin 200 mg/kg group (the same as below). , compared to the normal control group; , , compared to the model group.